Regulation (EC) No 1223/2009 (Article 13) requires that the responsible persons and, under certain circumstances, the distributors of cosmetic products submit some information about the products they place or make available on the European market through the CPNP.

Poison Centres or similar bodies established by EU countries (for the purposes of medical treatment).

The CPNP is accessible to:

Competent Authorities

European Poison Centres

Cosmetic products responsible persons

Distributors of cosmetic products.

Products containing nanomaterials

The CPNP also contains a separate module (Article 16) for cosmetic products containing nanomaterials. This notification has to be done in addition to the notification under Article 13. If the European Commission has concerns regarding the safety of a nanomaterial, it may request the Scientific Committee on Consumer Safety to perform a risk assessment.